Skip to main navigation Skip to search Skip to main content

98% SVR12 in Korean and Taiwanese patients with chronic GT1 HCV infection receiving 12-weeks of ledipasvir/sofosbuvir: A phase 3 study

  • Rong-Nan Chien
  • , Wan-Long Chuang
  • , Cheng-Yuan Peng
  • , Ting-Tsung Chang
  • , Chi-Jen Chu
  • , Jenny C. Yang
  • , Horng-Yuan Wang
  • , I-Shyan Sheen
  • , Yu-Chun Hsu
  • , Jia-Horng Kao

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
Pages (from-to)20-20
JournalJournal of Gastroenterology and Hepatology
Volume30
StatePublished - 2015

Cite this